Interface Biologics Raises C$5 Million
Interface Biologics Inc., a Toronto-based developer of biomedical-polymers for use in implantable medical devices, has raised C$5 million in new VC funding. Return backers include Covington Capital, VG Partners and BDC Capital.
9 December 2008•3 mins read
